Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

Three VHIR professionals, winners of the Institut Català de la Salut Research Awards

Dr. Arturo Evangelista and Carmen Fuentelsaz were awarded for their Research Trajectory. Dr. María Jesús Cruz, awarded for the best Basic Research Poster.

News

Vall d'Hebron hosts a day on amyotrophic lateral sclerosis

The meeting, of a clinical and research nature, comes this year with interesting news regarding the treatments for this neurodegenerative disease.

News

4th call for VHIR’s Master in Translational Biomedical Research scholarships

With this program, the VHIR aims to attract international talent and promote the formation of the best students of the 2017-2018 promotion.

News

A study of Vall d’Hebron opens a new therapeutic strategy for melanoma treatment

The novel drug, DIMATE, leads tumor cells to death, including the cancer stem cells or tumor reservoir.

News

A work to improve desensitization to chemotherapy, awarded at the SCAIC Congress

The Congress of the Catalan Society of Alergology and Clinical Immunology has awarded the work of Dr. Anna Sala, researcher of the Research Group on Systemic Diseases.

News

The Transplant Run gets € 23,215 for research into pediatric transplants

The solidarity race for the group of transplant patients allocates its revenues to fund research and assistance of paediatric transplant patients at Vall d'Hebron.

News

A clinical study of Vall d'Hebron identifies the subtype of virus that infects patients of Hepatitis C

Knowing which subtype of Hepatitis C virus causes hepatitis is a determining factor when choosing the treatment. The subtype of virus is determined thanks to the high resolution mass sequencing. Almost 1,500 Hospital patients participated in the study.

News

MIT selects a project to develop a new molecular kit for the diagnosis of endometrial cancer

CEMARK has allowed to determine a few biomarkers with high sensitivity and specificity for the differential diagnosis of endometrial cancer.

News

Fashion and medical research, go together with Intropia

The benefits will be destined to finance the predoctoral grant of Berta Sáez, researcher of the Pneumology research group at VHIR.

News

Dr. Albert Selva O'Callaghan, Head of Systemic Diseases Research Group, will be the new Head of the Department of Medicine at the UAB

"Enthusiasm, effort, excellence and commitment" are the words that define the new professional era that is just beginning.

News

A urine test could help diagnose graft dysfunction in kidney transplants

Researchers have discovered in the urine of patients' various proteins that allow to distinguish whether the dysfunction is due to organ rejection or infection by BK virus.

News

The EU-NCL network will support a project of nanomedicine for prostate cancer

Pre-clinical trials will be made with a polymer that transports therapeutic paclitaxel which has proven to be a good candidate to reach the clinical phase.

News

Vall d'Hebron is the leader in number of clinical trials against advanced melanoma

The Melanoma Biomedical Research Group in VHIR focuses on the study of the molecular basis of melanoma progression and resistance to current therapies.

News

VHIR researchers verify the therapeutic potential of autophagy inhibition for certain tumours

They proposed as a future objective to be able to predict which tumours would benefit from a therapeutic approach based on the autophagic inhibition.

News

El Síndrome de la Fatiga Crònica: una entitat clínica ben definida i amb segell molecular específic

La XV Jornada d'Avenços en el Síndrome de Fatiga Crònica va ser organitzada i acollida per l'Hospital Vall d'HebronLes últimes novetats en el diagnòstic d'aquest síndrome van ser exposades durant les Jornades

News

International award for young researchers in Hepatology

The researcher of the VHIR Salvador Augustin receives an international award for young researchers in Hepatology of the company Gilead

News

BAAS Arquitectura and Espinet/Ubach will design the new research building and the future transformation of Vall d'Hebron

The winning project is a building that seeks to melt into the surroundings by means of a Mediterranean and sustainable architecture. It will have an area of 5,000 m2 expandable.

News

Dual pathology and woman, a problem beyond medicine

Normal1 Only between 10 and 15% of women who undergo a dual pathology treatment keep working.

News

Nanoparticles against cancer in the Live Research Fair

From 3 to 6 May, researchers from the Nanomedicine group brought their laboratory to Cosmocaixa Barcelona

News

The Innovation Unit of VHIR awarded the Tecnio Facilitators label

Vall d'Hebron Research Institute (VHIR) has been the only institute of health research that has managed to obtain the TECNIO label in this call